Glendon Scott Bemis, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 509 North St., Chester, VT 05143 Phone: 802-875-4113 |
Mrs. Cortney Amber Donohue Slobodnjak, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 14 Main St., Chester, VT 05143 Phone: 802-558-1989 |
Mr. Robert Frederick Wubbenhorst, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 246 Flamstead Rd, Chester, VT 05143 Phone: 802-428-2008 |
Ms. Mara E. Cicaloni, M.S., LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 287 Main St., Chester, VT 05143 Phone: 802-875-5335 Fax: 802-875-5337 |
News Archive
Cancer remains a deadly threat despite the best efforts of science. New hopes were raised a few years ago with the discovery that the uncontrolled growth of cancer cells could be thwarted by blocking the action of proteasomes. Biochemists at the Technische Universitaet Muenchen (TUM) have illuminated a reaction pathway that does just that, in collaboration with researchers from Nereus Pharmaceuticals, based in San Diego, California. In the current issue of the Journal of Medicinal Chemistry, they report insights that could potentially lead to the development of custom-tailored anti-cancer drugs.
A neuroimaging study in the Sept. 1 issue of the journal Sleep is the first to find that cognitive processes related to verbal fluency are compromised in people with insomnia despite the absence of a behavioral deficit. These specific brain function alterations can be reversed, however, through non-pharmacological treatment with sleep therapy.
Today, the U.S. Food and Drug Administration authorized marketing of a new device intended to be worn around the neck of athletes aged 13 years and older during sports activities to aid in the protection of the brain from the effects associated with repetitive sub-concussive head impacts.
Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced the expansion of their genetic test menu. The new genetic test, nucSEEKPDx, will sequence approximately 1,100 nuclear genes constituting the mitochondrial exome, which encodes the vast majority of proteins found in the mitochondrion. This test is by far the most comprehensive test on the market for the management of mitochondrial disorders.
Scientists at the National Eye Institute have found that neurons in the superior colliculus, an ancient midbrain structure found in all vertebrates, are key players in allowing us to detect visual objects and events.
› Verified 4 days ago